Feed Insights Top Reports Pricing

⌘K

17:03:01·842d

SECFilingvia Quantisnow

SEC Form 10-K filed by Nasdaq Inc.

ByQuantisnow·Wall Street's wire, on your screen.

NDAQ· Nasdaq Inc.

Finance

Plus alert sent

Quantisnow Plus members were alerted at 17:03:02 ET - 1.9s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment NDAQ files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NDAQ (Nasdaq Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

Director Spaht Paul Holden Jr. was granted 2,998 shares (SEC Form 4)
Director Yabuki Jeffery W was granted 4,612 shares, increasing direct ownership by 25% to 22,959 units (SEC Form 4)
Director Begley Charlene T was granted 2,998 shares, increasing direct ownership by 7% to 48,999 units (SEC Form 4)
Director Koch Kathryn A. was granted 3,171 shares, increasing direct ownership by 42% to 10,743 units (SEC Form 4)
Director Zollar Alfred W was granted 4,497 shares, increasing direct ownership by 8% to 58,281 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022